Tempus AI Revenue 1970-1969 | TEM
- Tempus AI revenue for the quarter ending December 31, 1969 was $0M, a NAN% increase year-over-year.
- Tempus AI revenue for the twelve months ending December 31, 1969 was $0M, a NAN% increase year-over-year.
- Tempus AI annual revenue for was $0B, a NAN% decline from .
- Tempus AI annual revenue for was $0B, a NAN% decline from .
- Tempus AI annual revenue for was $0B, a NAN% decline from .
Tempus AI Annual Revenue (Millions of US $) |
---|
Tempus AI Quarterly Revenue (Millions of US $) |
---|
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $5.769B | $0.000B |
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $35.568B | 19.53 |
Hims & Hers Health (HIMS) | United States | $4.337B | 0.00 |
Inspire Medical Systems (INSP) | United States | $3.976B | 0.00 |
Axonics (AXNX) | United States | $3.430B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.348B | 0.00 |
Olink Holding AB (publ) (OLK) | Sweden | $3.168B | 0.00 |
Azenta (AZTA) | United States | $2.836B | 159.46 |
Enovis (ENOV) | United States | $2.479B | 18.37 |
10x Genomics (TXG) | United States | $2.318B | 0.00 |
Privia Health (PRVA) | United States | $2.074B | 115.87 |
Schrodinger (SDGR) | United States | $1.406B | 0.00 |
Omnicell (OMCL) | United States | $1.243B | 42.97 |
Phreesia (PHR) | United States | $1.217B | 0.00 |
Standard BioTools (LAB) | United States | $0.656B | 0.00 |
Definitive Healthcare (DH) | United States | $0.644B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.611B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.587B | 0.00 |
Talkspace (TALK) | United States | $0.390B | 0.00 |
Health Catalyst (HCAT) | United States | $0.377B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.299B | 0.00 |
Pulmonx (LUNG) | United States | $0.246B | 0.00 |
Outset Medical (OM) | United States | $0.199B | 0.00 |
Butterfly Network (BFLY) | United States | $0.177B | 0.00 |
TruBridge (TBRG) | United States | $0.150B | 8.06 |
P3 Health Partners (PIII) | United States | $0.142B | 0.00 |
American Well (AMWL) | United States | $0.096B | 0.00 |
111 (YI) | China | $0.091B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.076B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.075B | 0.00 |
HeartBeam (BEAT) | United States | $0.068B | 0.00 |
Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
MSP Recovery (LIFW) | United States | $0.064B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.045B | 0.00 |
Augmedix (AUGX) | United States | $0.043B | 0.00 |
Zepp Health (ZEPP) | China | $0.036B | 0.00 |
Akili (AKLI) | United States | $0.034B | 0.00 |
CareCloud (CCLD) | United States | $0.031B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.029B | 0.00 |
Movano (MOVE) | United States | $0.027B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.027B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
Syra Health (SYRA) | United States | $0.009B | 0.00 |
Biotricity (BTCY) | United States | $0.008B | 0.00 |
Transgenomic (PRPO) | United States | $0.008B | 0.00 |
Predictive Oncology (POAI) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.003B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |